Amicus Therapeutics (FOLD) – Guidance
-
Amicus Therapeutics (FOLD) Reports Prelim FY23 Revenue, Provides 2024 Outlook
-
Amicus Therapeutics (FOLD) Prelim. FY Revenue Tops Consensus
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to FOLD Stock Lookup